These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3818147

  • 1. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL, Halstenson CE, Abraham PA, Matzke GR.
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of piperacillin in hospitalized patients.
    Lau A, Lee M, Sharifi R.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):391-4. PubMed ID: 4044070
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of moxalactam in anuric children and during hemodialysis.
    Kaplan SL, Berry PL, Mason EO, Kramer WG.
    Pediatr Pharmacol (New York); 1983 Dec; 3(1):29-36. PubMed ID: 6646877
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL.
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 10. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.
    Giron JA, Meyers BR, Hirschman SZ, Srulevitch E.
    Antimicrob Agents Chemother; 1981 Feb; 19(2):279-83. PubMed ID: 6214987
    [Abstract] [Full Text] [Related]

  • 15. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A, Stamatakis G, Torlotin JC, Fredj G, Kenouch S, Méry JP.
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB, Norris K, Modi N, Sinha-Hikim I, Shen R, Davidson T, Bhasin S.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [Abstract] [Full Text] [Related]

  • 18. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
    Lee CS, Wang LH, Marbury TC, Bruni J, Perchalski RJ.
    Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.